img

Global Herceptin Biosimilar Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Herceptin Biosimilar Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy drugs. It is also termed as a targeted therapy drug. Trastuzumab is the one of the brand name herceptin which is administered by slow injection to a vein.
Herceptin Biosimilar report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Herceptin Biosimilar market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital & Clinics and Oncology Centers are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Herceptin Biosimilar industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Herceptin Biosimilar key manufacturers include Amgen, AryoGen Biopharma, Biocon, Celltrion, Gedeon Richter, Genor Biopharma, Mabion, Mylan and Roche, etc. Amgen, AryoGen Biopharma, Biocon are top 3 players and held % sales share in total in 2022.
Herceptin Biosimilar can be divided into Breast Cancer, Colorectal Cancer, Leukemia and Lymphoma, etc. Breast Cancer is the mainstream product in the market, accounting for % sales share globally in 2022.
Herceptin Biosimilar is widely used in various fields, such as Hospital & Clinics, Oncology Centers and Other,, etc. Hospital & Clinics provides greatest supports to the Herceptin Biosimilar industry development. In 2022, global % sales of Herceptin Biosimilar went into Hospital & Clinics filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Herceptin Biosimilar market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Amgen
AryoGen Biopharma
Biocon
Celltrion
Gedeon Richter
Genor Biopharma
Mabion
Mylan
Roche
The Instituto Vital Brazil
Segment by Type
Breast Cancer
Colorectal Cancer
Leukemia
Lymphoma
Other

Segment by Application


Hospital & Clinics
Oncology Centers
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Herceptin Biosimilar market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Herceptin Biosimilar, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Herceptin Biosimilar industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Herceptin Biosimilar in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Herceptin Biosimilar introduction, etc. Herceptin Biosimilar Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Herceptin Biosimilar market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Herceptin Biosimilar Market Overview
1.1 Herceptin Biosimilar Product Overview
1.2 Herceptin Biosimilar Market Segment by Type
1.2.1 Breast Cancer
1.2.2 Colorectal Cancer
1.2.3 Leukemia
1.2.4 Lymphoma
1.2.5 Other
1.3 Global Herceptin Biosimilar Market Size by Type
1.3.1 Global Herceptin Biosimilar Market Size Overview by Type (2018-2034)
1.3.2 Global Herceptin Biosimilar Historic Market Size Review by Type (2018-2024)
1.3.3 Global Herceptin Biosimilar Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Herceptin Biosimilar Sales Breakdown by Type (2018-2024)
1.4.2 Europe Herceptin Biosimilar Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Herceptin Biosimilar Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Herceptin Biosimilar Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Herceptin Biosimilar Sales Breakdown by Type (2018-2024)
2 Global Herceptin Biosimilar Market Competition by Company
2.1 Global Top Players by Herceptin Biosimilar Sales (2018-2024)
2.2 Global Top Players by Herceptin Biosimilar Revenue (2018-2024)
2.3 Global Top Players by Herceptin Biosimilar Price (2018-2024)
2.4 Global Top Manufacturers Herceptin Biosimilar Manufacturing Base Distribution, Sales Area, Product Type
2.5 Herceptin Biosimilar Market Competitive Situation and Trends
2.5.1 Herceptin Biosimilar Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Herceptin Biosimilar Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Herceptin Biosimilar as of 2022)
2.7 Date of Key Manufacturers Enter into Herceptin Biosimilar Market
2.8 Key Manufacturers Herceptin Biosimilar Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Herceptin Biosimilar Status and Outlook by Region
3.1 Global Herceptin Biosimilar Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Herceptin Biosimilar Historic Market Size by Region
3.2.1 Global Herceptin Biosimilar Sales in Volume by Region (2018-2024)
3.2.2 Global Herceptin Biosimilar Sales in Value by Region (2018-2024)
3.2.3 Global Herceptin Biosimilar Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Herceptin Biosimilar Forecasted Market Size by Region
3.3.1 Global Herceptin Biosimilar Sales in Volume by Region (2024-2034)
3.3.2 Global Herceptin Biosimilar Sales in Value by Region (2024-2034)
3.3.3 Global Herceptin Biosimilar Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Herceptin Biosimilar by Application
4.1 Herceptin Biosimilar Market Segment by Application
4.1.1 Hospital & Clinics
4.1.2 Oncology Centers
4.1.3 Other
4.2 Global Herceptin Biosimilar Market Size by Application
4.2.1 Global Herceptin Biosimilar Market Size Overview by Application (2018-2034)
4.2.2 Global Herceptin Biosimilar Historic Market Size Review by Application (2018-2024)
4.2.3 Global Herceptin Biosimilar Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Herceptin Biosimilar Sales Breakdown by Application (2018-2024)
4.3.2 Europe Herceptin Biosimilar Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Herceptin Biosimilar Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Herceptin Biosimilar Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Herceptin Biosimilar Sales Breakdown by Application (2018-2024)
5 North America Herceptin Biosimilar by Country
5.1 North America Herceptin Biosimilar Historic Market Size by Country
5.1.1 North America Herceptin Biosimilar Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Herceptin Biosimilar Sales in Volume by Country (2018-2024)
5.1.3 North America Herceptin Biosimilar Sales in Value by Country (2018-2024)
5.2 North America Herceptin Biosimilar Forecasted Market Size by Country
5.2.1 North America Herceptin Biosimilar Sales in Volume by Country (2024-2034)
5.2.2 North America Herceptin Biosimilar Sales in Value by Country (2024-2034)
6 Europe Herceptin Biosimilar by Country
6.1 Europe Herceptin Biosimilar Historic Market Size by Country
6.1.1 Europe Herceptin Biosimilar Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Herceptin Biosimilar Sales in Volume by Country (2018-2024)
6.1.3 Europe Herceptin Biosimilar Sales in Value by Country (2018-2024)
6.2 Europe Herceptin Biosimilar Forecasted Market Size by Country
6.2.1 Europe Herceptin Biosimilar Sales in Volume by Country (2024-2034)
6.2.2 Europe Herceptin Biosimilar Sales in Value by Country (2024-2034)
7 Asia-Pacific Herceptin Biosimilar by Region
7.1 Asia-Pacific Herceptin Biosimilar Historic Market Size by Region
7.1.1 Asia-Pacific Herceptin Biosimilar Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Herceptin Biosimilar Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Herceptin Biosimilar Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Herceptin Biosimilar Forecasted Market Size by Region
7.2.1 Asia-Pacific Herceptin Biosimilar Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Herceptin Biosimilar Sales in Value by Region (2024-2034)
8 Latin America Herceptin Biosimilar by Country
8.1 Latin America Herceptin Biosimilar Historic Market Size by Country
8.1.1 Latin America Herceptin Biosimilar Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Herceptin Biosimilar Sales in Volume by Country (2018-2024)
8.1.3 Latin America Herceptin Biosimilar Sales in Value by Country (2018-2024)
8.2 Latin America Herceptin Biosimilar Forecasted Market Size by Country
8.2.1 Latin America Herceptin Biosimilar Sales in Volume by Country (2024-2034)
8.2.2 Latin America Herceptin Biosimilar Sales in Value by Country (2024-2034)
9 Middle East and Africa Herceptin Biosimilar by Country
9.1 Middle East and Africa Herceptin Biosimilar Historic Market Size by Country
9.1.1 Middle East and Africa Herceptin Biosimilar Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Herceptin Biosimilar Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Herceptin Biosimilar Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Herceptin Biosimilar Forecasted Market Size by Country
9.2.1 Middle East and Africa Herceptin Biosimilar Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Herceptin Biosimilar Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Amgen
10.1.1 Amgen Company Information
10.1.2 Amgen Introduction and Business Overview
10.1.3 Amgen Herceptin Biosimilar Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Amgen Herceptin Biosimilar Products Offered
10.1.5 Amgen Recent Development
10.2 AryoGen Biopharma
10.2.1 AryoGen Biopharma Company Information
10.2.2 AryoGen Biopharma Introduction and Business Overview
10.2.3 AryoGen Biopharma Herceptin Biosimilar Sales, Revenue and Gross Margin (2018-2024)
10.2.4 AryoGen Biopharma Herceptin Biosimilar Products Offered
10.2.5 AryoGen Biopharma Recent Development
10.3 Biocon
10.3.1 Biocon Company Information
10.3.2 Biocon Introduction and Business Overview
10.3.3 Biocon Herceptin Biosimilar Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Biocon Herceptin Biosimilar Products Offered
10.3.5 Biocon Recent Development
10.4 Celltrion
10.4.1 Celltrion Company Information
10.4.2 Celltrion Introduction and Business Overview
10.4.3 Celltrion Herceptin Biosimilar Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Celltrion Herceptin Biosimilar Products Offered
10.4.5 Celltrion Recent Development
10.5 Gedeon Richter
10.5.1 Gedeon Richter Company Information
10.5.2 Gedeon Richter Introduction and Business Overview
10.5.3 Gedeon Richter Herceptin Biosimilar Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Gedeon Richter Herceptin Biosimilar Products Offered
10.5.5 Gedeon Richter Recent Development
10.6 Genor Biopharma
10.6.1 Genor Biopharma Company Information
10.6.2 Genor Biopharma Introduction and Business Overview
10.6.3 Genor Biopharma Herceptin Biosimilar Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Genor Biopharma Herceptin Biosimilar Products Offered
10.6.5 Genor Biopharma Recent Development
10.7 Mabion
10.7.1 Mabion Company Information
10.7.2 Mabion Introduction and Business Overview
10.7.3 Mabion Herceptin Biosimilar Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Mabion Herceptin Biosimilar Products Offered
10.7.5 Mabion Recent Development
10.8 Mylan
10.8.1 Mylan Company Information
10.8.2 Mylan Introduction and Business Overview
10.8.3 Mylan Herceptin Biosimilar Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Mylan Herceptin Biosimilar Products Offered
10.8.5 Mylan Recent Development
10.9 Roche
10.9.1 Roche Company Information
10.9.2 Roche Introduction and Business Overview
10.9.3 Roche Herceptin Biosimilar Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Roche Herceptin Biosimilar Products Offered
10.9.5 Roche Recent Development
10.10 The Instituto Vital Brazil
10.10.1 The Instituto Vital Brazil Company Information
10.10.2 The Instituto Vital Brazil Introduction and Business Overview
10.10.3 The Instituto Vital Brazil Herceptin Biosimilar Sales, Revenue and Gross Margin (2018-2024)
10.10.4 The Instituto Vital Brazil Herceptin Biosimilar Products Offered
10.10.5 The Instituto Vital Brazil Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Herceptin Biosimilar Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Herceptin Biosimilar Industrial Chain Analysis
11.4 Herceptin Biosimilar Market Dynamics
11.4.1 Herceptin Biosimilar Industry Trends
11.4.2 Herceptin Biosimilar Market Drivers
11.4.3 Herceptin Biosimilar Market Challenges
11.4.4 Herceptin Biosimilar Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Herceptin Biosimilar Distributors
12.3 Herceptin Biosimilar Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Breast Cancer
Table 2. Major Company of Colorectal Cancer
Table 3. Major Company of Leukemia
Table 4. Major Company of Lymphoma
Table 5. Major Company of Other
Table 6. Global Herceptin Biosimilar Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Herceptin Biosimilar Sales by Type (2018-2024) & (K Units)
Table 8. Global Herceptin Biosimilar Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Herceptin Biosimilar Sales by Type (2018-2024) & (US& Million)
Table 10. Global Herceptin Biosimilar Market Share in Value by Type (2018-2024)
Table 11. Global Herceptin Biosimilar Price by Type (2018-2024) & (USD/Unit)
Table 12. Global Herceptin Biosimilar Sales by Type (2024-2034) & (K Units)
Table 13. Global Herceptin Biosimilar Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Herceptin Biosimilar Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Herceptin Biosimilar Sales Market Share in Value by Type (2024-2034)
Table 16. Global Herceptin Biosimilar Price by Type (2024-2034) & (USD/Unit)
Table 17. North America Herceptin Biosimilar Sales by Type (2018-2024) & (K Units)
Table 18. North America Herceptin Biosimilar Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Herceptin Biosimilar Sales (K Units) by Type (2018-2024)
Table 20. Europe Herceptin Biosimilar Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Herceptin Biosimilar Sales (K Units) by Type (2018-2024)
Table 22. Asia-Pacific Herceptin Biosimilar Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Herceptin Biosimilar Sales (K Units) by Type (2018-2024)
Table 24. Latin America Herceptin Biosimilar Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Herceptin Biosimilar Sales (K Units) by Type (2018-2024)
Table 26. Middle East and Africa Herceptin Biosimilar Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Herceptin Biosimilar Sales by Company (2018-2024) & (K Units)
Table 28. Global Herceptin Biosimilar Sales Share by Company (2018-2024)
Table 29. Global Herceptin Biosimilar Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Herceptin Biosimilar Revenue Share by Company (2018-2024)
Table 31. Global Market Herceptin Biosimilar Price by Company (2018-2024) & (USD/Unit)
Table 32. Global Herceptin Biosimilar Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Herceptin Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Herceptin Biosimilar as of 2022)
Table 35. Date of Key Manufacturers Enter into Herceptin Biosimilar Market
Table 36. Key Manufacturers Herceptin Biosimilar Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Herceptin Biosimilar Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Herceptin Biosimilar Sales by Region (2018-2024) & (K Units)
Table 40. Global Herceptin Biosimilar Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Herceptin Biosimilar Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Herceptin Biosimilar Sales Market Share in Value by Region (2018-2024)
Table 43. Global Herceptin Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 44. Global Herceptin Biosimilar Sales by Region (2024-2034) & (K Units)
Table 45. Global Herceptin Biosimilar Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Herceptin Biosimilar Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Herceptin Biosimilar Sales Market Share in Value by Region (2024-2034)
Table 48. Global Herceptin Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 49. Global Herceptin Biosimilar Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Herceptin Biosimilar Sales by Application (2018-2024) & (K Units)
Table 51. Global Herceptin Biosimilar Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Herceptin Biosimilar Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Herceptin Biosimilar Sales Market Share in Value by Application (2018-2024)
Table 54. Global Herceptin Biosimilar Price by Application (2018-2024) & (USD/Unit)
Table 55. Global Herceptin Biosimilar Sales by Application (2024-2034) & (K Units)
Table 56. Global Herceptin Biosimilar Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Herceptin Biosimilar Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Herceptin Biosimilar Sales Market Share in Value by Application (2024-2034)
Table 59. Global Herceptin Biosimilar Price by Application (2024-2034) & (USD/Unit)
Table 60. North America Herceptin Biosimilar Sales by Application (2018-2024) (K Units)
Table 61. North America Herceptin Biosimilar Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Herceptin Biosimilar Sales by Application (2018-2024) (K Units)
Table 63. Europe Herceptin Biosimilar Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Herceptin Biosimilar Sales by Application (2018-2024) (K Units)
Table 65. Asia-Pacific Herceptin Biosimilar Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Herceptin Biosimilar Sales by Application (2018-2024) (K Units)
Table 67. Latin America Herceptin Biosimilar Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Herceptin Biosimilar Sales by Application (2018-2024) (K Units)
Table 69. Middle East and Africa Herceptin Biosimilar Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Herceptin Biosimilar Sales by Country (2018-2024) & (K Units)
Table 71. North America Herceptin Biosimilar Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Herceptin Biosimilar Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Herceptin Biosimilar Sales Market Share in Value by Country (2018-2024)
Table 74. North America Herceptin Biosimilar Sales by Country (2024-2034) & (K Units)
Table 75. North America Herceptin Biosimilar Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Herceptin Biosimilar Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Herceptin Biosimilar Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Herceptin Biosimilar Sales by Country (2018-2024) & (K Units)
Table 79. Europe Herceptin Biosimilar Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Herceptin Biosimilar Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Herceptin Biosimilar Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Herceptin Biosimilar Sales by Country (2024-2034) & (K Units)
Table 83. Europe Herceptin Biosimilar Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Herceptin Biosimilar Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Herceptin Biosimilar Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Herceptin Biosimilar Sales by Region (2018-2024) & (K Units)
Table 87. Asia-Pacific Herceptin Biosimilar Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Herceptin Biosimilar Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Herceptin Biosimilar Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Herceptin Biosimilar Sales by Region (2024-2034) & (K Units)
Table 91. Asia-Pacific Herceptin Biosimilar Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Herceptin Biosimilar Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Herceptin Biosimilar Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Herceptin Biosimilar Sales by Country (2018-2024) & (K Units)
Table 95. Latin America Herceptin Biosimilar Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Herceptin Biosimilar Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Herceptin Biosimilar Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Herceptin Biosimilar Sales by Country (2024-2034) & (K Units)
Table 99. Latin America Herceptin Biosimilar Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Herceptin Biosimilar Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Herceptin Biosimilar Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Herceptin Biosimilar Sales by Country (2018-2024) & (K Units)
Table 103. Middle East and Africa Herceptin Biosimilar Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Herceptin Biosimilar Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Herceptin Biosimilar Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Herceptin Biosimilar Sales by Country (2024-2034) & (K Units)
Table 107. Middle East and Africa Herceptin Biosimilar Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Herceptin Biosimilar Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Herceptin Biosimilar Sales Market Share in Value by Country (2024-2034)
Table 110. Amgen Company Information
Table 111. Amgen Introduction and Business Overview
Table 112. Amgen Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Amgen Herceptin Biosimilar Product
Table 114. Amgen Recent Development
Table 115. AryoGen Biopharma Company Information
Table 116. AryoGen Biopharma Introduction and Business Overview
Table 117. AryoGen Biopharma Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. AryoGen Biopharma Herceptin Biosimilar Product
Table 119. AryoGen Biopharma Recent Development
Table 120. Biocon Company Information
Table 121. Biocon Introduction and Business Overview
Table 122. Biocon Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. Biocon Herceptin Biosimilar Product
Table 124. Biocon Recent Development
Table 125. Celltrion Company Information
Table 126. Celltrion Introduction and Business Overview
Table 127. Celltrion Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 128. Celltrion Herceptin Biosimilar Product
Table 129. Celltrion Recent Development
Table 130. Gedeon Richter Company Information
Table 131. Gedeon Richter Introduction and Business Overview
Table 132. Gedeon Richter Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 133. Gedeon Richter Herceptin Biosimilar Product
Table 134. Gedeon Richter Recent Development
Table 135. Genor Biopharma Company Information
Table 136. Genor Biopharma Introduction and Business Overview
Table 137. Genor Biopharma Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 138. Genor Biopharma Herceptin Biosimilar Product
Table 139. Genor Biopharma Recent Development
Table 140. Mabion Company Information
Table 141. Mabion Introduction and Business Overview
Table 142. Mabion Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 143. Mabion Herceptin Biosimilar Product
Table 144. Mabion Recent Development
Table 145. Mylan Company Information
Table 146. Mylan Introduction and Business Overview
Table 147. Mylan Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 148. Mylan Herceptin Biosimilar Product
Table 149. Mylan Recent Development
Table 150. Roche Company Information
Table 151. Roche Introduction and Business Overview
Table 152. Roche Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 153. Roche Herceptin Biosimilar Product
Table 154. Roche Recent Development
Table 155. The Instituto Vital Brazil Company Information
Table 156. The Instituto Vital Brazil Introduction and Business Overview
Table 157. The Instituto Vital Brazil Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 158. The Instituto Vital Brazil Herceptin Biosimilar Product
Table 159. The Instituto Vital Brazil Recent Development
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Herceptin Biosimilar Market Trends
Table 163. Herceptin Biosimilar Market Drivers
Table 164. Herceptin Biosimilar Market Challenges
Table 165. Herceptin Biosimilar Market Restraints
Table 166. Herceptin Biosimilar Distributors List
Table 167. Herceptin Biosimilar Downstream Customers
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Herceptin Biosimilar Product Picture
Figure 2. Global Herceptin Biosimilar Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Herceptin Biosimilar Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Herceptin Biosimilar Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Breast Cancer
Figure 6. Global Breast Cancer Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Colorectal Cancer
Figure 8. Global Colorectal Cancer Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Leukemia
Figure 10. Global Leukemia Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Lymphoma
Figure 12. Global Lymphoma Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Product Picture of Other
Figure 14. Global Other Sales YoY Growth (2018-2034) & (K Units)
Figure 15. Global Herceptin Biosimilar Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Herceptin Biosimilar Sales Market Share by Type in 2022 & 2034
Figure 17. North America Herceptin Biosimilar Sales Market Share in Volume by Type in 2022
Figure 18. North America Herceptin Biosimilar Sales Market Share in Value by Type in 2022
Figure 19. Europe Herceptin Biosimilar Sales Market Share in Volume by Type in 2022
Figure 20. Europe Herceptin Biosimilar Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Herceptin Biosimilar Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Herceptin Biosimilar Sales Market Share in Value by Type in 2022
Figure 23. Latin America Herceptin Biosimilar Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Herceptin Biosimilar Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Herceptin Biosimilar Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Herceptin Biosimilar Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Herceptin Biosimilar Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Herceptin Biosimilar Revenue in 2022
Figure 29. Herceptin Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Hospital & Clinics
Figure 31. Global Hospital & Clinics Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Oncology Centers
Figure 33. Global Oncology Centers Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Product Picture of Other
Figure 35. Global Other Sales YoY Growth (2018-2034) & (K Units)
Figure 36. Global Herceptin Biosimilar Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Herceptin Biosimilar Sales Market Share by Application in 2022 & 2034
Figure 38. North America Herceptin Biosimilar Sales Market Share in Volume by Application in 2022
Figure 39. North America Herceptin Biosimilar Sales Market Share in Value by Application in 2022
Figure 40. Europe Herceptin Biosimilar Sales Market Share in Volume by Application in 2022
Figure 41. Europe Herceptin Biosimilar Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Herceptin Biosimilar Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Herceptin Biosimilar Sales Market Share in Value by Application in 2022
Figure 44. Latin America Herceptin Biosimilar Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Herceptin Biosimilar Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Herceptin Biosimilar Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Herceptin Biosimilar Manufacturing Cost Structure
Figure 49. Herceptin Biosimilar Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries